Lawmaker accuses Hanmi, Drug Ministry of falsehoods
Oct 7, 2016
[ THE INVESTOR ] Hanmi Pharmaceutical was aware of the negative side effects of targeted cancer therapy Olmutinib in August, an opposition lawmaker claimed on Oct. 7. Rep. Jung Choun-sook of the main opposition Minjoo Party of Korea revealed a document from Boehringer Ingelheim informing Hanmi of canceling all clinical trials sent on Aug. 23. In the statement, Boehringer Ingelheim stated th...